CEACAM5 and neoplasm: In summary, PD-L1 serves as a key indicator for guiding the use of immune checkpoint inhibitors, while CA125 and CEA, as classical serum tumor markers, are indispensable in auxiliary diagnosis, therapeutic efficacy monitoring, and prognostic assessment.